Search Within

Mark E Robson

Formats
  1. Journal Article (383)
  2. Meeting Abstract (262)
  3. Review (11)
  4. Book Section (7)
  5. Guidelines (7)
  6. Editorial (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (682)
  2. Department of Medicine (682)
  3. Population Sciences Research Program (682)
  4. Solid Tumor Oncology Division (682)
  5. Survivorship Research (682)
  6. GSK Faculty (379)

More Groups

People
  1. Kenneth Offit (280)
  2. Zsofia Stadler (116)
  3. Larry Norton (90)
  4. Vijai Joseph (79)
  5. Diana Mandelker (74)
  6. Michael Berger (67)

More People

Years
  1. 2025 (7)
  2. 2024 (33)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (166)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (19)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (188)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Elsevier Inc. (52)
  6. Oxford University Press (43)

More Publishers

Results (682)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ASO Visual Abstract: Association of moderate-risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease
    Miscellaneous

    Zhang, J. Q.; Dos Anjos, C. H.; Sevilimedu, V.; Crown, A.; Amoroso, K. A.; Pilewskie, M. L.; Robson, M. E.; Gemignani, M. L.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Mutational status is associated with higher rate of pathologic complete response after neoadjuvant chemotherapy in hormone receptor-positive breast cancer
    Miscellaneous

    Myers, S. P.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Association of moderate-risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease
    Journal Article

    Zhang, J. Q.; Dos Anjos, C. H.; Sevilimedu, V.; Crown, A.; Amoroso, K. A.; Pilewskie, M. L.; Robson, M. E.; Gemignani, M. L.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study
    Journal Article

    Turner, N. C.; Laird, A. D.; Telli, M. L.; Rugo, H. S.; Mailliez, A.; Ettl, J.; Grischke, E. M.; Mina, L. A.; BalmanĖƒa, J.; Fasching, P. A.; more...
    npj Breast Cancer (2023)

    Fulltext@MSK | Save
  • BRCA mutational status is associated with higher rate of pathologic complete response in hormone receptor-positive breast cancer
    Meeting Abstract

    Myers, S. P.; Walsh, E. M.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
    Journal Article

    Morra, A.; Schreurs, M. A. C.; Andrulis, I. L.; Anton-Culver, H.; Augustinsson, A.; Beckmann, M. W.; Behrens, S.; Bojesen, S. E.; Bolla, M. K.; Brauch, H.; more...
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Electro-acupuncture versus battle field auricular acupuncture in breast cancer survivors with chronic musculoskeletal pain: Subgroup analysis of a randomized clinical trial
    Journal Article

    Bao, T.; Zhi, W. I.; Baser, R. E.; Li, Q. S.; Weitzman, M.; Gillespie, E. F.; Robson, M.; Mao, J. J.
    Breast Cancer Research and Treatment (2023)

    Fulltext@MSK | Save
  • Harnessing olaparib, palbociclib, and endocrine therapy: A phase I/II trial of olaparib, palbociclib and fulvestrant in patients with BRCA mutation-associated, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (HOPE)
    Meeting Abstract

    Torres, A.; Aaron, M.; White, L.; D'Andrea, K.; Narayan, V.; Knollman, H. M.; Bradbury, A. R.; Tung, N. M.; Robson, M. E.; Nathanson, K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX-7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction
    Meeting Abstract

    Shen, S.; Solomon, V.; Williams, D.; Robson, M. E.; Norton, L.; Traina, T. A.; Iyengar, N. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Early integration of exercise into breast cancer care: The MSK healthy living program
    Meeting Abstract

    Rowed, K.; Shen, S.; Smith, A.; Kelly, B.; Magnoli, R.; Corcoran, S.; Emerzian, M.; Ackerman, K.; Cruz, C.; Salehi, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save